BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9504172)

  • 1. Effects of mastoid cavity obliteration on the growth of experimentally produced residual cholesteatoma.
    Hinohira Y; Gyo K; Yanagihara N; Bredberg G; Alsterborg E
    Acta Otolaryngol; 1998 Jan; 118(1):101-4. PubMed ID: 9504172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cholesteatomas arising from autologous free skin grafting in the middle ear cavity.
    Hinohira Y; Gyo K; Yanagihara N
    Acta Otolaryngol; 1994 Sep; 114(5):533-8. PubMed ID: 7825436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual cholesteatoma: an experimental study in guinea pigs].
    Sasaki Y
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Feb; 98(2):260-6. PubMed ID: 7707184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obliteration of the mastoid air cell system with porous tricalcium phosphate ceramic. An animal experiment of the bulla tympanica of the pig (author's transl)].
    Zöllner C; Strutz J; Beck C; Büsing CM; Jahnke K; Heimke G
    Laryngol Rhinol Otol (Stuttg); 1981 Oct; 60(10):527-33. PubMed ID: 7345281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demineralized bone matrix as an alternative for mastoid obliteration and posterior canal wall reconstruction: results in an animal model.
    Leatherman BD; Dornhoffer JL; Fan CY; Mukunyadzi P
    Otol Neurotol; 2001 Nov; 22(6):731-6. PubMed ID: 11698788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
    Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
    Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Configuration of experimentally produced cholesteatoma by transplantation of a free skin graft.
    Gyo K; Sasaki Y; Hinohira Y
    J Laryngol Otol; 1996 Jul; 110(7):629-31. PubMed ID: 8759533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
    Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
    Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mastoid obliteration techniques in cholesteatoma.
    Yung M; Bennett A
    Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy.
    Minoda R; Hayashida M; Masuda M; Yumoto E
    Otol Neurotol; 2007 Dec; 28(8):1018-21. PubMed ID: 17898672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastoid cavity obliteration: our experience.
    Deshmukh S; Sharma A; Dabholkar J
    Otolaryngol Pol; 2012; 66(6):379-81. PubMed ID: 23200556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
    Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
    J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma.
    Hellingman CA; Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
    Laryngoscope; 2019 Apr; 129(4):981-985. PubMed ID: 30408197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastoid obliteration with hydroxyapatite--the value of high resolution CT scanning in detecting recurrent cholesteatoma.
    Yung MM; Karia KR
    Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):553-7. PubMed ID: 9466070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mastoid cavity obliteration with allogenic and autologous material].
    Weiss N; Stallbaum T; Botzen J; Bächinger D; Großmann W; Bernd HE; Mlynski R
    Laryngorhinootologie; 2022 Jan; 101(1):40-44. PubMed ID: 33946124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications with hydroxyapatite cement in mastoid cavity obliteration.
    Ridenour JS; Poe DS; Roberson DW
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):641-5. PubMed ID: 18984257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of the evidence for open cavity, combined approach and reconstruction of the mastoid cavity in primary cholesteatoma surgery.
    Harris AT; Mettias B; Lesser TH
    J Laryngol Otol; 2016 Mar; 130(3):235-41. PubMed ID: 26878375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.